Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$866K Buy
+12,870
New +$857K ﹤0.01% 2256
2026
Q1
– Sell
-3,810
Closed -$265K – 4004
2025
Q4
$252K Sell
3,810
-50,748
-93% -$3.28M ﹤0.01% 2490
2025
Q3
$3.67M Buy
+54,558
New +$4.32M 0.01% 819
2025
Q2
– Sell
-84,970
Closed -$5.8M – 2830
2025
Q1
$5.8M Sell
84,970
-201,552
-70% -$16.4M 0.04% 383
2024
Q4
$22.3M Buy
+286,522
New +$21.2M 0.12% 107
2023
Q4
– Sell
-50,470
Closed -$4.71M – 2472
2023
Q3
$4.71M Buy
+50,470
New +$5.69M 0.05% 319
2023
Q2
– Sell
-72,056
Closed -$8.37M – 2643
2023
Q1
$8.37M Sell
72,056
-96,649
-57% -$10.8M 0.1% 168
2022
Q4
$19.1M Buy
168,705
+143,519
+570% +$15.8M 0.27% 61
2022
Q3
$2.03M Sell
25,186
-20,128
-44% -$1.7M 0.02% 597
2022
Q2
$3.38M Buy
+45,314
New +$4.14M 0.04% 366
2022
Q1
– Sell
-6,296
Closed -$689K – 3272
2021
Q4
$845K Buy
+6,296
New +$905K ﹤0.01% 1278
2020
Q3
– Sell
-167,816
Closed -$17M – 1994
2020
Q2
$17M Buy
+167,816
New +$15M 0.51% 34
2019
Q4
– Sell
-20,708
Closed -$772K – 1260
2019
Q3
$772K Buy
+20,708
New +$805K 0.04% 470
2019
Q2
– Sell
-10,816
Closed -$322K – 786
2019
Q1
$322K Buy
+10,816
New +$380K 0.05% 276
2018
Q4
– Sell
-8,972
Closed -$320K – 625
2018
Q3
$320K Buy
+8,972
New +$278K 0.05% 240

Other funds holding DXCM

HRT Financial's DXCM Position: Q2 2026 in Review

HRT Financial opened a new position in DexCom (DXCM) in Q2 2026: 12,870 shares worth $866K. The stake represents ﹤0.01% of the portfolio and ranks #2256 among its holdings. This is a return to the name: HRT Financial previously reported a position in DXCM as recently as Q4 2025.

HRT Financial first reported a position in DXCM in Q3 2018 and has held it in 15 quarters since. The position peaked at $22.3M in Q4 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HRT Financial held 12,870 shares of DexCom worth $866K as of Q2 2026.
  • DexCom was a new HRT Financial position in Q2 2026.
  • DexCom made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2256 holding.
  • HRT Financial first reported a position in DexCom in Q3 2018 and has held it in 15 quarters since.
  • HRT Financial's DexCom position peaked at $22.3M in Q4 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.